Drug Safety Oversight Initiatives Spur CDRH Postmarket Soul-Searching
The recent spotlight on drug safety is prompting FDA's Center for Devices & Radiological Health to re-examine its regulatory approach to devices
The recent spotlight on drug safety is prompting FDA's Center for Devices & Radiological Health to re-examine its regulatory approach to devices